New study to focus on treatment for long Covid that causes symptoms like brain fog, sleep disorder
long COVID, an anxiously awaited step in U.S. efforts against the mysterious condition that afflicts millions. Monday's announcement from the NIH's USD 1.15 billion RECOVER project comes amid frustration from patients who've struggled for months or even years with sometimes-disabling health problems — with no proven treatments and only a smattering of rigorous studies to test potential ones.
«This is a year or two late and smaller in scope than one would hope but nevertheless it's a step in the right direction,» said Dr. Ziyad Al-Aly of Washington University in St. Louis, who isn't involved with NIH's project but whose own research highlighted long COVID's toll.
Getting answers is critical, he added, because «there's a lot of people out there exploiting patients' vulnerability» with unproven therapies. Scientists don't yet know what causes long COVID, the catchall term for about 200 widely varying symptoms. Between 10 per cent and 30 per cent of people are estimated to have experienced some form of long COVID after recovering from a coronavirus infection, a risk that has dropped somewhat since early in the pandemic.
«If I get 10 people, I get 10 answers of what long COVID really is,» U.S. Health and Human Services Secretary Xavier Becerra said. That's why so far the RECOVER initiative has tracked 24,000 patients in observational studies to help define the most common and burdensome symptoms — findings that now are shaping multipronged treatment trials.
Read more on economictimes.indiatimes.com
